{"disease":{"id":"dyskinesia","name":"dyskinesia"},"drugs":{"marketed":[{"drug_id":"valbenazine","indication_name":"Tardive Dyskinesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ingrezza","generic_name":"valbenazine","company_name":"Neurocrine","drug_phase":"marketed","molecular_target":"Potassium voltage-gated channel subfamily H member 2, Synaptic vesicular amine transporter, Synaptic vesicular amine transporter","drug_class":"","quality_score":55,"revenue":"1900","mechanism":null},{"drug_id":"valbenazine","indication_name":"Tardive dyskinesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ingrezza","generic_name":"valbenazine","company_name":"Neurocrine","drug_phase":"marketed","molecular_target":"Potassium voltage-gated channel subfamily H member 2, Synaptic vesicular amine transporter, Synaptic vesicular amine transporter","drug_class":"","quality_score":55,"revenue":"1900","mechanism":null},{"drug_id":"deutetrabenazine","indication_name":"Tardive dyskinesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Austedo","generic_name":"DEUTETRABENAZINE","company_name":"Teva","drug_phase":"marketed","molecular_target":"Synaptic vesicular amine transporter","drug_class":"","quality_score":70,"revenue":"1100","mechanism":"Austedo works by binding to the synaptic vesicular amine transporter, reducing the release of dopamine and other neurotransmitters."},{"drug_id":"deutetrabenazine","indication_name":"Tardive dyskinesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Austedo","generic_name":"DEUTETRABENAZINE","company_name":"Teva","drug_phase":"marketed","molecular_target":"Synaptic vesicular amine transporter","drug_class":"","quality_score":70,"revenue":"1100","mechanism":"Austedo works by binding to the synaptic vesicular amine transporter, reducing the release of dopamine and other neurotransmitters."},{"drug_id":"aclatonium","indication_name":"Biliary dyskinesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Abovis","generic_name":"ACLATONIUM","company_name":"","drug_phase":"phase_2","molecular_target":"Muscarinic acetylcholine receptor","drug_class":"aclatonium","quality_score":23,"revenue":null,"mechanism":"Abovis works by binding to the muscarinic acetylcholine receptor, a protein that plays a key role in regulating various bodily functions."},{"drug_id":"flopropione","indication_name":"Biliary dyskinesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cospanon","generic_name":"FLOPROPIONE","company_name":"","drug_phase":"phase_2","molecular_target":"Catechol O-methyltransferase","drug_class":"","quality_score":null,"revenue":null,"mechanism":"FLOPROPIONE works by inhibiting the enzyme Catechol O-methyltransferase, which plays a role in the regulation of bile flow."}],"pipeline":[],"offLabel":[],"totalMarketed":6,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04949308","title":"Nasal Nitric Oxide Across Mutations in Primary Ciliary Dyskinesia","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"University Hospital Muenster","has_results":false},{"nct_id":"NCT04717115","title":"Genotype/Phenotype Correlation With Focus on Lung Function in Primary Ciliary Dyskinesia (PCD)","phase":"","overall_status":"UNKNOWN","enrollment_count":1500,"lead_sponsor_name":"University Hospital Muenster","has_results":false},{"nct_id":"NCT04602481","title":"Living With Primary Ciliary Dyskinesia (Living With PCD)","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"University of Bern","has_results":false},{"nct_id":"NCT05317390","title":"Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia","phase":"NA","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Massachusetts Eye and Ear Infirmary","has_results":false},{"nct_id":"NCT00105508","title":"Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":506,"lead_sponsor_name":"EMD Serono","has_results":true},{"nct_id":"NCT06585605","title":"A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Boston Children's Hospital","has_results":false},{"nct_id":"NCT06481007","title":"ALgerian Cholecystectomy Outcomes and Determinants Study (AL-CODS)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"University of Oran 1","has_results":false},{"nct_id":"NCT04476433","title":"Intervention in Chronic Pediatric Patients and Their Families.","phase":"NA","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"University of Valencia","has_results":false},{"nct_id":"NCT07274631","title":"A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine","phase":"","overall_status":"RECRUITING","enrollment_count":470,"lead_sponsor_name":"CHU de Reims","has_results":false},{"nct_id":"NCT03704896","title":"PRospective Observational Multicentre Study on VAriability of Lung Function in Stable PCD Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":451,"lead_sponsor_name":"University of Southampton","has_results":false},{"nct_id":"NCT04702243","title":"Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults","phase":"","overall_status":"COMPLETED","enrollment_count":436,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":false},{"nct_id":"NCT00105521","title":"Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":398,"lead_sponsor_name":"EMD Serono","has_results":true},{"nct_id":"NCT02198794","title":"Reducing Involuntary Movements in Participants With Tardive Dyskinesia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":343,"lead_sponsor_name":"Auspex Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT06011408","title":"Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes","phase":"NA","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"iRxReminder","has_results":false},{"nct_id":"NCT05951478","title":"DCP (RaDiCo Cohort) (RaDiCo-DCP)","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Institut National de la Santé Et de la Recherche Médicale, France","has_results":false},{"nct_id":"NCT06842966","title":"Efficacy, Safety, and Tolerability of 4-MUST Tablets in Chronic Cholecystitis and Biliary Dyskinesia","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Valenta Pharm JSC","has_results":false},{"nct_id":"NCT04453995","title":"A Follow-up of the Influencing Factors of Dyskinesia in Patients With Parkinson's Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT02291861","title":"Addressing Involuntary Movements in Tardive Dyskinesia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":298,"lead_sponsor_name":"Auspex Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT03176771","title":"Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":256,"lead_sponsor_name":"Tanabe Pharma Corporation","has_results":true},{"nct_id":"NCT03704207","title":"Utility of PCD Diagnostics to Improve Clinical Care","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT02736955","title":"Rollover Study for Continuing Valbenazine (NBI-98854) Administration for the Treatment of Tardive Dyskinesia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":161,"lead_sponsor_name":"Neurocrine Biosciences","has_results":true},{"nct_id":"NCT06618209","title":"Assessment of Oral Health Status of Children With Primary Ciliary Dyskinesia","phase":"","overall_status":"COMPLETED","enrollment_count":160,"lead_sponsor_name":"Marmara University","has_results":false},{"nct_id":"NCT04919018","title":"Characterizing the Upper Airway Manifestations in Primary Ciliary Dyskinesia and Primary Immunodeficiencies","phase":"","overall_status":"COMPLETED","enrollment_count":159,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":false},{"nct_id":"NCT04173845","title":"Double Randomized and Placebo Controlled Trail of Tianqi Pingchan Granule to Prevent Levodopa-Induced Dyskinesia","phase":"NA","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT03891862","title":"Persistence of Effect and Safety of Valbenazine for the Treatment of Tardive Dyskinesia","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":135,"lead_sponsor_name":"Neurocrine Biosciences","has_results":true},{"nct_id":"NCT02153632","title":"Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":135,"lead_sponsor_name":"Adamas Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT07023224","title":"Reliability and Validity Study of the Turkish Version of the Parkinson's Disease Dyskinesia Scale (PDYS-26)","phase":"","overall_status":"RECRUITING","enrollment_count":130,"lead_sponsor_name":"Izmir Bakircay University","has_results":false},{"nct_id":"NCT04086160","title":"Effects of Transcranial Direct Current Stimulation (tDCS) on Motor Function in Schizophrenia Patients and Individuals at Risk for Psychotic Onset","phase":"NA","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Dr WANG Shumei","has_results":false},{"nct_id":"NCT03494894","title":"Bacteriological Link Between Upper and Lower Airways in Cystic Fibrosis and Primary Ciliary Dyskinesia","phase":"","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Centre Hospitalier Intercommunal Creteil","has_results":false},{"nct_id":"NCT06731868","title":"Safety and Efficacy of LPM3770164 Sustained-release Tablets in Patients With Tardive Dyskinesia","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Luye Pharma Group Ltd.","has_results":false},{"nct_id":"NCT05161858","title":"Longitudinal Characterization of Respiratory Tract Exacerbations and Treatment Responses in Primary Ciliary Dyskinesia","phase":"","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":false},{"nct_id":"NCT05297201","title":"Efficacy, Safety and Pharmacokinetic Study of CPL500036 in Patients with Levodopa Induced Dyskinesia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"Celon Pharma SA","has_results":false},{"nct_id":"NCT05238701","title":"A Dose-escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of LPM3770164 in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":104,"lead_sponsor_name":"Luye Pharma Group Ltd.","has_results":false},{"nct_id":"NCT04173832","title":"Clinical Study on Treatment of L-DOPA-Induced Dyskinesia With Tianqi Pingchan Granule Combined With Amantadine","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT04064294","title":"Preventing Levodopa Induced Dyskinesia in Parkinson's Disease With HMG-CoA Reductase Inhibitors","phase":"","overall_status":"COMPLETED","enrollment_count":93,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT03956979","title":"A Study in Parkinson's Disease in Patients With Moderate to Severe Dyskinesia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":89,"lead_sponsor_name":"Contera Pharma","has_results":false},{"nct_id":"NCT03698331","title":"The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":89,"lead_sponsor_name":"Neurocrine Biosciences","has_results":true},{"nct_id":"NCT07148362","title":"Upper Extremity Exercise Capacity, Muscle Oxygenation, and Balance in Pediatric CF and PCD","phase":"","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"Gazi University","has_results":false},{"nct_id":"NCT07157644","title":"Exercise Capacity, Muscle Oxygenation, Respiratory Muscle Strength, and Physical Activity Level in Pediatric CF and PCD","phase":"","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"Gazi University","has_results":false},{"nct_id":"NCT00368446","title":"Genetic Disorders of Mucociliary Clearance in Nontuberculous Mycobacterial Lung Disease","phase":"","overall_status":"COMPLETED","enrollment_count":87,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT02153645","title":"Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID.","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":87,"lead_sponsor_name":"Adamas Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT05516693","title":"Chewing, Swallowing and Orofacial Motricity in Severe Obese","phase":"NA","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Centro Universitário de Anapolis","has_results":false},{"nct_id":"NCT04161313","title":"Respiratory Function, Exercise Capacity and Peripheral Muscle Strength Among Patients With CF, PCD and Healthy Children","phase":"","overall_status":"COMPLETED","enrollment_count":76,"lead_sponsor_name":"Bezmialem Vakif University","has_results":false},{"nct_id":"NCT01474421","title":"Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":71,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT06570824","title":"rTMS as an Intervention for Levodopa-induced Dyskinesia","phase":"NA","overall_status":"RECRUITING","enrollment_count":68,"lead_sponsor_name":"Danish Research Centre for Magnetic Resonance","has_results":false},{"nct_id":"NCT05816876","title":"Muscle Function, Exercise Capacity and Physical Activity Level in Primary Ciliary Dyskinesia and Kartagener Syndrome","phase":"","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"Gazi University","has_results":false},{"nct_id":"NCT03497013","title":"Effect of tDCS on Cognition, Symptoms in Chronic Schizophrenia Patients With Tardive Dyskinesia","phase":"NA","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"Suzhou Psychiatric Hospital","has_results":false},{"nct_id":"NCT07173920","title":"Single-Center, Double-Blind, Randomized, Placebo-Controlled Study on Efficacy and Safety of rTMS (With Precise Localization) in Relieving Motor Symptoms of TD","phase":"NA","overall_status":"RECRUITING","enrollment_count":62,"lead_sponsor_name":"Peking University Sixth Hospital","has_results":false},{"nct_id":"NCT03256773","title":"High Resolution Micro OCT Imaging","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":60,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":false},{"nct_id":"NCT04553835","title":"Effects of Rhythmic Auditory Stimulation on Movements in Individuals at Risk for Psychotic Onset and Schizophrenia Patients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Dr WANG Shumei","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}